Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)

Oncol Rep. 2016 Aug;36(2):603-12. doi: 10.3892/or.2016.4886. Epub 2016 Jun 21.

Abstract

Endocrine disruptors (EDs) are pollutants that alter the endocrine system and are involved in carcinogenesis. EDs have multiple and complex levels of action. They can affect the synthesis, release and transport of natural hormones. In target tissues, EDs can reduce or increase the effects of natural hormones on their receptors and change signaling cascades. When ED exposure happens at critical periods of life, from embryo to puberty, they can act at doses considered safe for an adult. Furthermore, their epigenetic effects can also influence the cancer risk of future generations. The cancer mechanisms of known EDs are hereby reviewed, There are thousands of newly introduced substances whose potential endocrine-disrupting and cancer effects are completely unknown. Although there are still gaps in our knowledge, these data support the urgent need for health and environmental policies aimed at protecting the public and in particular, the developing fetus and women of reproductive age.

Publication types

  • Review

MeSH terms

  • Animals
  • Carcinogenesis / drug effects*
  • Endocrine Disruptors / pharmacology*
  • Endocrine Disruptors / therapeutic use*
  • Epigenesis, Genetic / drug effects
  • Female
  • Humans
  • Neoplasms / drug therapy*
  • Signal Transduction / drug effects

Substances

  • Endocrine Disruptors